Elephant's Foot: Hepatoprotective Claims and the Glutathione Question

Liver protection is one of the four traditional indications recorded almost everywhere this plant grows — jaundice and hepatitis remedies from Vietnam to southern China to Indonesia. The rodent evidence behind it is real and comes from several independent groups. It also runs directly into the plant's own defining chemistry: the sesquiterpene lactones responsible for most of Elephant's Foot's interesting biology work by consuming glutathione, and glutathione conjugation is one of the liver's central detoxification jobs. This page holds both facts at once rather than picking the flattering one, and it flags a retracted study along the way — a finding worth having whether or not you ever take this plant.


Table of Contents

  1. The Traditional Claim, Across Traditions
  2. The Core Rodent Evidence: Five Toxin Models
  3. A Direct Species Comparison: Scaber, Mollis, and a Third Genus
  4. Teng-Khia-U Again: The Same Mixture Problem
  5. A Retracted Study, Named
  6. The Glutathione Question: How a Protective Compound Can Also Be a Burden
  7. Reconciling It: A Dose-and-Context Duality, Not a Contradiction to Resolve Away
  8. A Combination Study in Pregnant Mice — and What It Does Not Show
  9. Why Sourcing Matters More Here Than Almost Anywhere Else
  10. Practical Bottom Line
  11. Key Research Papers
  12. Connections
  13. Featured Videos

The Traditional Claim, Across Traditions

Liver protection appears independently across every tradition this plant is used in. Vietnamese thuốc nam decocts the whole plant for jaundice and liver complaints. Southern Chinese practice under the name di dan cao ("earth gall herb," a name that itself references bitterness as a marker of liver-clearing medicine) records acute hepatitis among its indications. Indonesian jamu uses tapak liman as a general "cleanser." This degree of independent convergence across traditions that did not share information is a real signal that the plant does something relevant to the liver — it is not, on its own, evidence that the something is beneficial, since a plant that stresses or challenges the liver could just as easily generate a "clearing" reputation as one that protects it.

Back to Table of Contents

The Core Rodent Evidence: Five Toxin Models

Four research groups have tested Elephantopus scaber extract against five different liver-toxin models in rodents (the carbon tetrachloride and NDEA papers come from the same laboratory), and all five studies reported a protective effect:

Five different toxins, four different research groups, one consistent direction of effect. This is a more solid rodent evidence base than most of the other claims on this site's Elephant's Foot pages, which is exactly why the complications below matter — they are not a reason to dismiss this evidence, but a reason to read it carefully.

Back to Table of Contents

A Direct Species Comparison: Scaber, Mollis, and a Third Genus

One 1991 paper did something unusual and genuinely useful: it tested three related taxa separately, head to head, against CCl4-induced liver injury in the same experiment — Elephantopus scaber subsp. oblanceolata, E. mollis, and Pseudoelephantopus spicatus, all benchmarked against Bupleurum chinense, an already-established hepatoprotective herb used as a positive comparator. The result: all three significantly lowered the rise in serum transaminases caused by CCl4 (E. scaber subsp. oblanceolata p<0.001; E. mollis and P. spicatus p<0.01), but only E. scaber subsp. oblanceolata and E. mollis clearly improved the fatty and necrotic liver-tissue damage, while P. spicatus showed only a moderate protective effect on the tissue.

This paper is genuinely useful specifically because it tested the species separately rather than as a blend — it is the strongest piece of evidence on this page that the hepatoprotective effect is not an artifact of one particular species being accidentally potent inside a mixture, and that at least E. scaber (in this case, a named subspecies of it) carries real activity on its own. It is still a single 1991 paper without modern methods or a large sample.

Back to Table of Contents

Teng-Khia-U Again: The Same Mixture Problem

As on the fever and inflammation page, a separate strand of Taiwanese hepatoprotection research tests "Teng-Khia-U" — explicitly, by its own authors' definition, a folk preparation made from the combined whole plants of E. scaber, E. mollis, and Pseudoelephantopus spicatus together. A 1995 paper in this series found Teng-Khia-U water extracts reduced liver-enzyme elevation (serum glutamate-oxaloacetate transaminase, sGOT, and serum glutamate-pyruvate transaminase, sGPT) and improved histological damage from both D-galactosamine and acetaminophen-induced acute liver injury in rats — two more toxin models than the five above, and two of real clinical relevance, since acetaminophen (paracetamol) overdose is a leading real-world cause of acute liver failure in humans.

The finding is real. It is, again, a finding about a three-species mixture rather than about Elephantopus scaber in isolation, and this page labels it that way rather than folding it silently into the single-species evidence count above.

Back to Table of Contents

A Retracted Study, Named

A 2013 paper from a Taiwanese research group (Tsai, Wu, Lin, and colleagues) reported that Elephantopus scaber extract promoted liver regeneration after partial hepatectomy in rats, via increased hepatocyte growth factor and insulin-like growth factor 1 (IGF-1) expression. This paper was formally retracted in 2017 by the journal (Evidence-Based Complementary and Alternative Medicine), with a published retraction notice. The retraction notice available through PubMed does not state the specific scientific reason for the retraction, and this page does not speculate about one it cannot verify — but the fact of retraction alone is sufficient reason to exclude this study from the evidence base entirely, and it is named here rather than silently dropped, because a builder who checked less carefully could easily have cited it as a positive finding. It is not being cited as one anywhere on this site.

Both the original record and its retraction notice are linked in the Key Research Papers list below by their PubMed identifiers, so the retraction can be checked directly.

Back to Table of Contents

The Glutathione Question: How a Protective Compound Can Also Be a Burden

Here is the tension this page exists to hold rather than resolve away. The main Elephant's Foot page explains that deoxyelephantopin and its relatives are Michael acceptors that react irreversibly with cysteine — and the single most abundant cysteine-containing molecule in a cell is glutathione, the body's principal antioxidant and detoxification reserve, synthesized and recycled predominantly in the liver. A compound that consumes glutathione is, all else equal, a burden on hepatic detoxification capacity, not a gift to it.

And yet a 2013 mechanistic study (Huang et al., Journal of Nutritional Biochemistry) specifically tested purified deoxyelephantopin — not whole extract — against fulminant hepatitis and reported a protective effect with identified mechanistic detail. In that study, mice given deoxyelephantopin (10 mg/kg) before the lipopolysaccharide/D-galactosamine liver challenge had 75% survival, and 62.5% with the treatments given after the challenge; when heme oxygenase-1 expression was also inhibited, survival fell to 50%, which suggests that this stress-response enzyme is part of how the protection works. Deoxyelephantopin given after the challenge, like the hepatoprotective drug silymarin used as a comparator, protected against liver-cell apoptosis (programmed cell death). This is not a contradiction this page can wave away with "more research is needed." Both findings are real, from serious peer-reviewed sources, about the same reactive chemistry.

Back to Table of Contents

Reconciling It: A Dose-and-Context Duality, Not a Contradiction to Resolve Away

The most defensible reading is not that one study is wrong, but that this chemistry behaves differently depending on dose and context — a pattern pharmacologists call hormesis, where a low dose of a mildly stressful compound triggers a protective adaptive response while a higher dose overwhelms the same system. Mild, transient depletion of glutathione and generation of reactive oxygen species is a recognized trigger for the cell's own antioxidant defense program, centered on the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) — the same pathway named explicitly in the neuroinflammation study on the fever and inflammation page. A low or moderate exposure could plausibly precondition liver cells to handle a subsequent toxic insult better (which is the design of most of the "pretreatment" hepatoprotection studies above — the extract is given before the toxin in most of them, testing prevention of an insult that has not happened yet, not treatment of existing liver damage; the exceptions are the 2013 NDEA study, which also had a curative arm, and the 2013 deoxyelephantopin study, which also gave the compound after the liver challenge). A higher, sustained, or already-compromised-liver exposure could plausibly do the opposite: add to an existing glutathione deficit rather than triggering a useful adaptive response.

This reconciliation is plausible and consistent with general toxicology, and it has not been directly tested for this specific compound at defined doses in this specific tissue. It is offered here as the most honest available account of two real, conflicting findings — not as a settled answer.

Back to Table of Contents

A Combination Study in Pregnant Mice — and What It Does Not Show

A 2021 study tested a combined extract of Sauropus androgynus and Elephantopus scaber against E. coli-induced renal and hepatic necrosis in pregnant mice, and found a protective, hormone-balancing effect. Two things are worth being precise about. First, most of its seven groups tested a two-herb combination; one group received Elephantopus scaber alone (200 mg/kg), which showed an immunomodulatory effect on Gr1+ immune cells, while the significant kidney and liver protection was reported for the 75:25 combination — so the same formula-substitution caution that applies to the Teng-Khia-U papers applies to most of its findings. Second, and more importantly given the caution on this plant's main page against use in pregnancy: this study tested protection against an induced bacterial infection in already-pregnant animals. It is not a reproductive or developmental toxicology study, and it says nothing about whether this plant is safe to take during pregnancy. The mice were dosed from day 1 to day 16 of pregnancy, and the study measured hormones, an immune-cell marker and kidney and liver tissue. A positive result in pregnant animals exposed to a specific infection model does not answer a completely different question — whether the plant itself affects a developing pregnancy — which remains untested and is exactly why the existing caution stands.

Back to Table of Contents

Why Sourcing Matters More Here Than Almost Anywhere Else

A 2026 analytical chemistry paper (Gao et al., Journal of Chromatography A) used untargeted metabolomics specifically to distinguish Elephantopus scaber from Elephantopus tomentosus — work undertaken precisely because the two species are difficult to tell apart by routine means and are traded under overlapping names. Combined with the CCl4 species-comparison study above (where E. scaber, E. mollis and P. spicatus showed different degrees of protection from each other) and the Teng-Khia-U mixture papers, the pattern across this entire page is consistent: related species and mixtures in this genus and its neighbors are not pharmacologically interchangeable, even though they are commonly sold and studied as if they were. For a plant whose main proposed liver benefit runs through a narrow, dose-sensitive chemical mechanism, not knowing exactly which plant (or which mixture) is in a given preparation is a bigger problem than it would be for a herb whose effect is more robust to species variation.

Back to Table of Contents

Practical Bottom Line

Back to Table of Contents

Key Research Papers

  1. Rajesh MG, Latha MS. Hepatoprotection by Elephantopus scaber Linn. in CCl4-induced liver injury (2001). Indian Journal of Physiology and Pharmacology. — PubMed PMID: 11883157
  2. Ho WY, Yeap SK, Ho CL, et al. Hepatoprotective Activity of Elephantopus scaber on Alcohol-Induced Liver Damage in Mice (2012). Evidence-Based Complementary and Alternative Medicine. — PubMed PMID: 22973401
  3. Linza A, Wills PJ, Ansil PN, et al. Dose-response effects of Elephantopus scaber methanolic extract on N-nitrosodiethylamine-induced hepatotoxicity in rats (2013). Chinese Journal of Natural Medicines. — PubMed PMID: 23845544
  4. Hung HF, Hou CW, Chen YL, et al. Elephantopus scaber inhibits lipopolysaccharide-induced liver injury by suppression of signaling pathways in rats (2011). The American Journal of Chinese Medicine. — PubMed PMID: 21721151
  5. Lin CC, Yen MH, Chiu HF. The pharmacological and pathological studies on Taiwan folk medicine (VI): The effects of Elephantopus scaber subsp. oblanceolata, E. mollis and Pseudoelephantopus spicatus (1991). The American Journal of Chinese Medicine. — PubMed PMID: 1897489 — The direct three-taxa comparison discussed above.
  6. Lin CC, Tsai CC, Yen MH. The evaluation of hepatoprotective effects of Taiwan folk medicine "teng-khia-u" (1995). Journal of Ethnopharmacology. — PubMed PMID: 7776660 — The abstract describes a three-species mixture.
  7. Sulistyani N, Nurkhasanah. Screening of anticancer, hepatoprotective and nephroprotective effects of ethanol extract of Elephantopus scaber L. (2020). Pakistan Journal of Pharmaceutical Sciences. — PubMed PMID: 33191211
  8. Gao W, Sun J, Wang F, et al. Deoxyelephantopin suppresses hepatic stellate cells activation associated with inhibition of aerobic glycolysis via hedgehog pathway (2019). Biochemical and Biophysical Research Communications. — PubMed PMID: 31296386 — Relevant to liver fibrosis specifically, a different endpoint from acute toxin protection.
  9. Huang CC, Lin KJ, Cheng YW, et al. Hepatoprotective effect and mechanistic insights of deoxyelephantopin, a phyto-sesquiterpene lactone, against fulminant hepatitis (2013). The Journal of Nutritional Biochemistry. — PubMed PMID: 22748804 — The purified-compound hepatoprotection finding central to the glutathione discussion above.
  10. Tsai CC, Wu JP, Lin YM, et al. The Effect of Elephantopus scaber L. on Liver Regeneration after Partial Hepatectomy (2013; retracted 2017). Evidence-Based Complementary and Alternative Medicine. — Original article: PubMed PMID: 23365606; retraction notice (2017): PubMed PMID: 29333183 — The original finding is not used as evidence on this site; see the discussion above.
  11. Gao CS, Duan ZK, Lian MY, et al. Untargeted metabolomics and in-house database analysis reveal differences between Elephantopus scaber L. and Elephantopus tomentosus L. (2026). Journal of Chromatography A. — PubMed PMID: 41806488
  12. Christina YI, Diana MR, Fuzianingsih EN, et al. Hormone-balancing and protective effect of combined extract of Sauropus androgynus and Elephantopus scaber against Escherichia coli-induced renal and hepatic necrosis in pregnant mice (2021). Journal of Ayurveda and Integrative Medicine. — PubMed PMID: 32958334 — A combination study; see the pregnancy caveat above.

PubMed Topic Searches

  1. Elephantopus scaber and liver
  2. Elephantopus scaber toxicity and safety
  3. Glutathione depletion and Michael-acceptor hepatotoxicity — background to the mechanism discussed above

Back to Table of Contents

Connections

Back to Table of Contents